Earlier quoted context omitted.
Such a crass statement. What if you're the patient? Would you spend 2 million to live 30-40 more years? It's so easy to step back and weight the lives of other as if you're making the decision for others.
The $2M represents a certain portion of society’s productivity, which is not unlimited.
FDA approves a CRISPR-based medicine for treatment of sickle cell disease
71–80 of 228 posts
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#72Earlier quoted context omitted.
Since the collective probability of rare, but expensive health issues is basically 100%, I would describe it less as insurance and more as wealth redistribution. Hence the (typical) requirement to purchase insurance and lack of ability to price it based on risk. Of course, insurance and taxation can be viewed as similar things anyway, but it is different from things like term life insurance or motor vehicle insurance…
> Since the collective probability of rare, but expensive health issues is basically 100%, I would describe it less as insurance and more as wealth redistribution. Humm no... It's just risk amortization...
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#73Earlier quoted context omitted.
Such a crass statement. What if you're the patient? Would you spend 2 million to live 30-40 more years? It's so easy to step back and weight the lives of other as if you're making the decision for others.
> What if you're the patient? What if you are on those 10 poor kids he mentioned ? I don't agree that OP statement is "crass". It's a very pragmatic and important question we have wrestle with.
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#74Earlier quoted context omitted.
> Id like to see the flood gates really open up for gene editing for diseases, preventative treatments, and even cosmetic. Me too, because it's fun to consider DNA as some code we can edit to get outcomes we want! However, some people are ethically opposed to that - but piggybacking on the preference people have for having children should be able to move the Overton window!
It really is inspiring. Yeah I take the opposite side, ethically speaking. I think its cruel to not allow people to fix their bodies in the ways they want and in many cases need. Im in the max body-editing camp. Also this should resolve race issues once and for all which is fun to think about.
I doubt it. One of the root causes of “race” issues is humans using prior probabilities. Unless that changes, then the priors will simply move on from being skin tone based. I would suggest they already have for some portions of the population.
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#75Earlier quoted context omitted.
This is Day 1 so the price and how well it works today is almost certainly the worst it will ever be. Insurance will likely cover the cost. It's a very bad, painful, and outright deadly genetic mutation and $2.2 million is practically nothing compared to doubling someone's lifespan or giving them an extra 10 years. More info I found relevant regarding cost for typical treatment and out of pocket estimated costs: http…
I don't agree that it is nothing. 2 millions, if applied properly, could do good for many people. Take ten children from poverty, give ten children chance to get a good education, etc. There is always a some kind of moral dilemma: should you spent millions to try to extend extremely I'll person or help with that money to some healthy poor children?
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#76> Vertex set the price of Casgevy at $2.2 million > Patients must spend weeks, even months, in the hospital before and after the therapy is administered. Yoiks. So how many actual people are going to be able to get this treatment?
Indeed. The good news is, it actually turns out to be about the same or cheaper than ongoing treatment of a untreated sickle cell: """Each treatment is an individualized “one-off” treatment. For this reason, a single treatment for a single patient is expensive. At present it is estimated that in the UK treatment will cost £1 million or more. In the US the estimated cost is $2 million. That may seem prohibitive, but w…
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#77Earlier quoted context omitted.
Hmmm. That second one reminds me of the Flavr Savr ( https://en.m.wikipedia.org/wiki/Flavr_Savr ). More shelf life in exchange for likely worse taste...
Worse taste but probably healthier in this case.
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#78The gene that causes sickle cell anaemia actually provides partial immunity to malaria, which is why this gene has not been bred out of the population over time.
> which is why this gene has not been bred out of the population over time. Is that why? Or is it just the people with it aren’t sick enough to die before procreating?
Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#79Re: FDA approves a CRISPR-based medicine for treatment of sickle cell disease
#80Earlier quoted context omitted.
> Since the collective probability of rare, but expensive health issues is basically 100%, I would describe it less as insurance and more as wealth redistribution. Humm no... It's just risk amortization...
Is it risk amortization because we just can't predict certain health issues? Let's suppose that we had a "health oracle" (or something not too far off) to predict medical issues in individuals. How would you structure health insurance in that case?